GLAUKOS Corp Induced Conversion of Convertible Debt Expense
GLAUKOS Corp (GKOS) reported Induced Conversion of Convertible Debt Expense of $18.01 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InducedConversionOfConvertibleDebtExpense · last filed 2026-02-23
- GLAUKOS Corp induced conversion of convertible debt expense for the quarter ending 2024-12-31 was $0.00.
- GLAUKOS Corp induced conversion of convertible debt expense for the quarter ending 2024-09-30 was $0.00.
- GLAUKOS Corp induced conversion of convertible debt expense for the quarter ending 2024-06-30 was $18.01M.
- GLAUKOS Corp induced conversion of convertible debt expense for fiscal 2024 was $18.01M.
| Period end | Induced Conversion of Convertible Debt Expense 3 month | Induced Conversion of Convertible Debt Expense 6 month | Induced Conversion of Convertible Debt Expense 9 month | Induced Conversion of Convertible Debt Expense 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $18.01M derived: sum of 3 quarters · filed 2026-02-23 | $18.01M 10-K · filed 2026-02-23 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $18.01M derived: sum of 2 quarters · filed 2025-10-31 | $18.01M 10-Q · filed 2025-10-31 | |
| 2024-06-30 | $18.01M 10-Q · filed 2025-08-04 | $18.01M 10-Q · filed 2025-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |